Abstract
The process of carcinogenesis involves a number of changes in cellular phenotype, which are largely based on acquired genetic changes in cells that are not terminally differentiated. The ability of cancer cells to grow and their failure to respond to the usual controls on such proliferation are obvious features, but they also evade cell death and most have no limits on their ability to replicate beyond the limits imposed by telomere length in normal cells. In addition, they are able to stimulate the formation of blood vessels to ensure a steady supply of oxygen and nutrients, and to invade normal tissues, sometimes subverting the normal processes within those tissues. Finally, it has become increasingly apparent that cancer cells undergo a process of selection which renders the immune system ineffective. Some of these characteristics are retained by cells in culture, and an understanding of the biological properties of cancer cells will assist in the design of experiments and the interpretation of their results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer, Cell 100, 57–70.
Knudson, A. G., Jr. (1971) Mutation and cancer: statistical study of retinoblastoma, Proc Natl Acad Sci USA 68, 820–823.
Kinzler, K. W., and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer, Cell 87, 159–170.
Soreide, K., Nedrebo, B. S., Knapp, J. C., Glomsaker, T. B., Soreide, J. A., and Korner, H. (2009) Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist, Surg Oncol 18, 31–50.
Darwin, C. (1859) The Origin of Species.
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., Silliman, N., Szabo, S., Dezso, Z., Ustyanksky, V., Nikolskaya, T., Nikolsky, Y., Karchin, R., Wilson, P. A., Kaminker, J. S., Zhang, Z., Croshaw, R., Willis, J., Dawson, D., Shipitsin, M., Willson, J. K., Sukumar, S., Polyak, K., Park, B. H., Pethiyagoda, C. L., Pant, P. V., Ballinger, D. G., Sparks, A. B., Hartigan, J., Smith, D. R., Suh, E., Papadopoulos, N., Buckhaults, P., Markowitz, S. D., Parmigiani, G., Kinzler, K. W., Velculescu, V. E., and Vogelstein, B. (2007) The genomic landscapes of human breast and colorectal cancers, Science 318, 1108–1113.
Hoque, M. O., Kim, M. S., Ostrow, K. L., Liu, J., Wisman, G. B., Park, H. L., Poeta, M. L., Jeronimo, C., Henrique, R., Lendvai, A., Schuuring, E., Begum, S., Rosenbaum, E., Ongenaert, M., Yamashita, K., Califano, J., Westra, W., van der Zee, A. G., Van Criekinge, W., and Sidransky, D. (2008) Genome-wide promoter analysis uncovers portions of the cancer methylome, Cancer Res 68, 2661–2670.
Salk, J. J., Fox, E. J., and Loeb, L. A. (2009) Mutational Heterogeneity in Human Cancers: Origin and Consequences, Annu Rev Pathol.
Cree, I. A., Neale, M. H., Myatt, N. E., de Takats, P. G., Hall, P., Grant, J., Kurbacher, C. M., Reinhold, U., Neuber, K., MacKie, R. M., Chana, J., Weaver, P. C., Khoury, G. G., Sartori, C., and Andreotti, P. E. (1999) Heterogeneity of chemosensitivity of metastatic cutaneous melanoma, Anticancer Drugs 10, 437–444.
Mehra, R., Han, B., Tomlins, S. A., Wang, L., Menon, A., Wasco, M. J., Shen, R., Montie, J. E., Chinnaiyan, A. M., and Shah, R. B. (2007) Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases, Cancer Res 67, 7991–7995.
Rosen, J. M., and Jordan, C. T. (2009) The increasing complexity of the cancer stem cell paradigm, Science 324, 1670–1673.
Perez-Soler, R. (2009) Individualized therapy in non-small-cell lung cancer: future versus current clinical practice, Oncogene 28 Suppl 1, S38–45.
Heinemann, V., Stintzing, S., Kirchner, T., Boeck, S., and Jung, A. (2009) Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR, Cancer Treat Rev 35, 262–271.
Knudson, A. G., Jr. (1978) Retinoblastoma: a prototypic hereditary neoplasm, Semin Oncol 5, 57–60.
Hallstrom, T. C., and Nevins, J. R. (2009) Balancing the decision of cell proliferation and cell fate, Cell Cycle 8, 532–535.
Vousden, K. H., and Lane, D. P. (2007) p53 in health and disease, Nat Rev Mol Cell Biol 8, 275–283.
Phelps, R. A., Broadbent, T. J., Stafforini, D. M., and Jones, D. A. (2009) New perspectives on APC control of cell fate and proliferation in colorectal cancer, Cell Cycle 8, 2549–2556.
Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer 26, 239–257.
Fulda, S. (2009) Tumor resistance to apoptosis, Int J Cancer 124, 511–515.
Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., and Haupt, Y. (2009) Tumour suppression by p53: the importance of apoptosis and cellular senescence, J Pathol 219, 3–15.
Hayflick, L., and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains, Exp Cell Res 25, 585–621.
De Boeck, G., Forsyth, R. G., Praet, M., and Hogendoorn, P. C. (2009) Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms, J Pathol 217, 327–344.
Keller, G., Brassat, U., Braig, M., Heim, D., Wege, H., and Brummendorf, T. H. (2009) Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy, Hematol Oncol 27, 123–129.
Ha, L., Merlino, G., and Sviderskaya, E. V. (2008) Melanomagenesis: overcoming the barrier of melanocyte senescence, Cell Cycle 7, 1944–1948.
Jain, R. K., Duda, D. G., Willett, C. G., Sahani, D. V., Zhu, A. X., Loeffler, J. S., Batchelor, T. T., and Sorensen, A. G. (2009) Biomarkers of response and resistance to antiangiogenic therapy, Nat Rev Clin Oncol 6, 327–338.
Ramjaun, A. R., and Hodivala-Dilke, K. (2009) The role of cell adhesion pathways in angiogenesis, Int J Biochem Cell Biol 41, 521–530.
Folberg, R., Hendrix, M. J., and Maniotis, A. J. (2000) Vasculogenic mimicry and tumor angiogenesis, Am J Pathol 156, 361–381.
Polak, M. E., Borthwick, N. J., Jager, M. J., and Cree, I. A. (2009) Melanoma vaccines-the problems of local immunosuppression, Hum Immunol.
Polak, M. E., Borthwick, N. J., Gabriel, F. G., Johnson, P., Higgins, B., Hurren, J., McCormick, D., Jager, M. J., and Cree, I. A. (2007) Mechanisms of local immunosuppression in cutaneous melanoma, Br J Cancer 96, 1879–1887.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Cree, I.A. (2011). Cancer Biology. In: Cree, I. (eds) Cancer Cell Culture. Methods in Molecular Biology, vol 731. Humana Press. https://doi.org/10.1007/978-1-61779-080-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-080-5_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-079-9
Online ISBN: 978-1-61779-080-5
eBook Packages: Springer Protocols